君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

香港特别行政区成立纪念日休市 06-30 16:08:07

16.650

-0.560

-3.25%

最高17.420	最低16.360	成交量673.94万
今开17.160	昨收17.210	日振幅6.16%
总市值171.00亿	流通市值43.29亿	总股本10.27亿
成交额1.13亿	换手率2.59%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":16.65,"timestamp":1782806887004,"preClose":17.21,"halted":0,"volume":6739402,"delay":0,"changeRate":-0.03253922138291704,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"香港特别行政区成立纪念日休市","change":-0.56,"latestTime":"06-30 16:08:07","open":17.16,"high":17.42,"low":16.36,"amount":113456559,"amplitude":0.061592,"askPrice":16.66,"askSize":5600,"bidPrice":16.65,"bidSize":3200,"shortable":3,"etf":0,"ttmEps":-0.691,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":7,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":17.21,"openAndCloseTimeList":[[1782783000000,1782792000000],[1782795600000,1782806400000]],"volumeRatio":1.5153791351754693,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物-U","latestPrice":35.9,"timestamp":1782889200000,"preClose":33.82,"halted":0,"volume":34703300,"delay":0,"premium":"-59.82"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2648549235","title":"君实生物（688180）披露与复星万邦签订授权许可协议，7月1日股价上涨6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648549235","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648549235?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:16","pubTimestamp":1782915378,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，君实生物报收于35.9元，较前一交易日上涨6.15%，最新总市值为368.58亿元。近日，上海君实生物医药科技股份有限公司与复星万邦（江苏）医药集团有限公司签订《授权许可协议》，授权其在大中华地区对偌考奇拜单抗的开发、注册、生产及商业化权利。公司可获得2.15亿元首付款，最高11.25亿元里程碑付款，以及大中华地区净销售额双位数百分比的分级销售提成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1583","688180","BK1161","BK1515","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648548383","title":"君实生物(01877.HK)与复星万邦签订《授权许可协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2648548383","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648548383?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:01","pubTimestamp":1782907291,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1515","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180332641","title":"君实生物将授予复星万邦等在华开发及销售Roconkibart（JS005）的权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1180332641","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180332641?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:39","pubTimestamp":1782905962,"startTime":"0","endTime":"0","summary":"君实生物宣布，将授予复星万邦生物医药（江苏）有限公司及其他相关方在大中华区开发、生产和商业化其创新药物Roconkibart（研发代号JS005）的独家权利。此举旨在加速该产品在呼吸系统疾病领域的临床开发与市场拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688180","BK1515","BK1161","BK1583","01877","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648756549","title":"君实生物与复星万邦就偌考奇拜单抗（IL-17A）达成研发和商业化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648756549","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648756549?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:00","pubTimestamp":1782903600,"startTime":"0","endTime":"0","summary":"上海2026年7月1日 /美通社/ -- 北京时间2026年7月1日，君实生物宣布与复星医药控股子公司复星万邦（江苏）医药集团有限公司于近日签署授权许可协议，双方就偌考奇拜单抗在大中华地区的开发、注册、生产及商业化达成合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4996311_ZH96311_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["688180","01877","BK0239","BK1515","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648514738","title":"君实生物：与复星万邦签订授权许可协议获2.15亿元首付款及最高11.25亿元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2648514738","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648514738?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:19","pubTimestamp":1782901179,"startTime":"0","endTime":"0","summary":"君实生物(688180.SH)公告称，公司与复星医药全资子公司复星万邦签订授权许可协议，授权其在大中华地区开发、注册、生产及商业化偌考奇拜单抗(抗IL-17A单抗)。公司将获得2.15亿元(含税)不可抵扣且不可退还的首付款，并有资格获得最高达11.25亿元(含税)的开发和销售里程碑付款，以及大中华地区净销售额双位数百分比的分级销售提成。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100036095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1515","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343514","title":"股市必读：6月26日君实生物现1笔大宗交易 机构净买入1987.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647343514?lang=zh_cn&edition=full","pubTime":"2026-06-29 02:54","pubTimestamp":1782672850,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，君实生物报收于29.68元，下跌5.27%，换手率2.22%，成交量17.01万手，成交额5.14亿元。大宗交易6月26日君实生物发生1笔大宗交易，机构净买入1987.63万元。出席股东所持表决权占公司总表决权的29.6324%。北京市嘉源律师事务所出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1515","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313177","title":"每周股票复盘：君实生物（688180）一周大宗交易累计超9700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646313177?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:30","pubTimestamp":1782585032,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，君实生物报收于29.68元，较上周的30.09元下跌1.36%。本周，君实生物6月24日盘中最高价报31.96元。本周关注点交易信息汇总：6月22日至6月26日君实生物连续5个交易日共发生5笔大宗交易，累计成交金额达9735.53万元。交易信息汇总6月26日君实生物现1笔大宗交易，机构净买入1987.63万元。6月25日发生1笔大宗交易，成交金额1992.32万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1161","BK1515","688180","BK1583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646350976","title":"君实生物(01877)选举陈良为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2646350976","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646350976?lang=zh_cn&edition=full","pubTime":"2026-06-26 21:09","pubTimestamp":1782479349,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)发布公告，有关选举陈良先生为独立非执行董事的第9项决议案已于2026年6月26日举行的股东周年大会上获批准。选举陈良先生为独立非执行董事已于股东周年大会当日(即2026年6月26日)生效。自2026年6月26日起，郦仲贤先生获选为审计委员会及薪酬与考核委员会主席以及战略与ESG委员会成员，陈良先生获选为审计委员会及合规委员会成员。任期均自股东会批准之日(即2026年6月26日)起生效，直至第四届董事会任期结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646330288","title":"6月26日君实生物跌5.27%，科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646330288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646330288?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:39","pubTimestamp":1782463172,"startTime":"0","endTime":"0","summary":"证券之星消息，6月26日君实生物跌5.27%，收盘报29.68元，换手率2.22%，成交量17.01万手，成交额5.14亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共32家，其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为12.41亿元，最新净值0.831，较上一交易日上涨2.06%。科创创新药ETF国泰的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","01877","BK1161","BK1515","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646833025","title":"君实生物跌5.27%，太平洋二个月前给出“买入”评级，目标价53.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646833025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646833025?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:39","pubTimestamp":1782463166,"startTime":"0","endTime":"0","summary":"今日君实生物（688180）跌5.27%，收盘报29.68元。2026年4月17日，太平洋研究员周豫,戎晓婕发布了对君实生物的研报《拓益保持高速增长，关注AACR大会JS207和JS212数据读出》，该研报对君实生物给出“买入”评级，认为其目标价为53.12元，研报发布时股价为44.38元，预期涨幅为19.69%。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为64.51%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中邮证券的盛丽华。君实生物（688180）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","601099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646242876","title":"6月25日君实生物发生1笔大宗交易 成交金额1992.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646242876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646242876?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:38","pubTimestamp":1782380300,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日君实生物发生大宗交易，交易数据如下：大宗交易成交价格31.13元，相对当日收盘价折价0.64%，成交64万股，成交金额1992.32万元，买方营业部为中信建投证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生13笔大宗交易，合计成交8.48万手，折价成交13笔。截至2026年6月25日收盘，君实生物报收于31.33元，下跌0.13%，换手率2.77%，成交量21.23万手，成交额6.47亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500032329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646840322","title":"【券商聚焦】中信证券：中国创新药BD交易金额超预期增长 即将进入密集数据催化期","url":"https://stock-news.laohu8.com/highlight/detail?id=2646840322","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646840322?lang=zh_cn&edition=full","pubTime":"2026-06-25 09:03","pubTimestamp":1782349398,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研报指，2026年以来，中国创新药BD交易金额超预期增长，产业全球竞争力进一步提升；国内市场快速放量，从2025年报来看，头部创新药企业在新产品驱动下，创新药收入快速增长，Biopharma陆续进入盈利拐点。研报认为创新药产业全球价值凸显，接下来将进入密集数据催化期。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984448","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","LU1813983027.USD","02269","01877","01177","01801","LU0823426480.USD","BD","LU0348767384.USD","LU1794554557.SGD","LU0501845795.SGD","LU1960683339.HKD","IE00B0JY6N72.USD","LU1226288253.USD","BK1574","159992","LU1064130708.USD","09995","IE0008368742.USD","LU1242518857.USD","06160","BK0196","SG9999002463.SGD","LU0540923850.HKD","BK0028","LU1328277881.USD","LU0359202008.SGD","LU2289578879.USD","02142","09688","LU2039709279.SGD","06030","06185","600030","LU2097828474.EUR","LU2328871848.SGD","LU0327786744.USD","02616","LU0405327148.USD","SG9999002562.SGD","BK1610","LU0856984785.SGD","06978","SG9999004220.SGD","IE00B5MMRT66.SGD","LU0181495838.USD","LU1997245094.SGD","09926","IE00BZ08YT58.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645564887","title":"6月23日君实生物现1笔大宗交易 机构净买入1905.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645564887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645564887?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:52","pubTimestamp":1782208366,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日君实生物发生大宗交易，交易数据如下：大宗交易成交价格30.24元，相对当日收盘价折价0.62%，成交63万股，成交金额1905.12万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生11笔大宗交易，合计成交7.21万手，折价成交11笔。截至2026年6月23日收盘，君实生物报收于30.43元，上涨0.93%，换手率2.35%，成交量18.0万手，成交额5.52亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300031111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1161","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645001206","title":"医药板块逆市走高 山东新华制药(00719)涨23.59%、康诺亚-B(02162)涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645001206","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645001206?lang=zh_cn&edition=full","pubTime":"2026-06-23 10:08","pubTimestamp":1782180500,"startTime":"0","endTime":"0","summary":"市场交易结构出现变化，医药与科技板块不再呈现明显跷跷板效应，医疗服务、CXO赛道带动板块韧性修复。临近二季度末，市场开始提前交易行业业绩预期，资金重点布局两大主线，分别为商业化放量提速的创新药标的，以及受益于投融资回暖的CXO、生命科学上游龙头。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984274","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","02268","06990","IE00BPRC5H50.USD","LU0456827905.SGD","IE00B5MMRT66.SGD","LU0516422366.SGD","LU1880383366.USD","00719","02162","LU0417516902.SGD","LU0140636845.USD","BK1576","LU0516422952.EUR","LU0051755006.USD","LU1720050803.USD","LU0327786744.USD","09995","LU0516423091.SGD","LU0856984785.SGD","BK1191","BK1583","LU0359201612.USD","09969","LU0320764599.SGD","IE00B0JY6N72.USD","LU3063872942.SGD","09939","LU0588546209.SGD","09688","09926","LU2328871848.SGD","LU0979878070.USD","02269","LU0039217434.USD","06160","LU2039709279.SGD","LU0326950275.SGD","LU0456846285.SGD","SG9999002562.SGD","LU0348783233.USD","LU1251922891.USD","159938","LU0052750758.USD","01877","BK1161","LU1242518857.USD","LU0307460666.USD","LU1303224171.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645013206","title":"股市必读：6月18日君实生物现1笔大宗交易 机构净买入1883.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645013206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645013206?lang=zh_cn&edition=full","pubTime":"2026-06-22 02:04","pubTimestamp":1782065056,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，君实生物报收于30.09元，上涨2.38%，换手率1.92%，成交量14.69万手，成交额4.41亿元。当日关注点交易信息汇总：6月18日主力资金净流入2523.82万元。大宗交易6月18日君实生物发生1笔大宗交易，机构净买入1883.07万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200000742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1161","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644063666","title":"每周股票复盘：君实生物（688180）机构连续四日参与大宗交易净买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2644063666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644063666?lang=zh_cn&edition=full","pubTime":"2026-06-20 01:57","pubTimestamp":1781891829,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，君实生物报收于30.09元，较上周的30.69元下跌1.96%。本周关注点来自交易信息汇总：6月15日至6月18日君实生物连续四日发生大宗交易，机构累计净买入超7900万元。交易信息汇总6月18日君实生物发生1笔大宗交易，机构净买入1883.07万元。6月16日君实生物发生1笔大宗交易，成交金额1958.88万元。期间股价下跌30.46%，截至6月15日收盘价为30.2元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","688180","01877","BK1515","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644772361","title":"股市必读：6月17日君实生物现1笔大宗交易 机构净买入2050.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644772361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644772361?lang=zh_cn&edition=full","pubTime":"2026-06-18 01:44","pubTimestamp":1781718256,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，君实生物报收于29.39元，下跌1.31%，换手率1.16%，成交量8.88万手，成交额2.62亿元。交易信息汇总：6月17日主力资金净流出2087.46万元，散户资金净流入2674.11万元。大宗交易6月17日君实生物发生1笔大宗交易，机构净买入2050.3万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644761786","title":"股市必读：6月16日君实生物发生1笔大宗交易 成交金额1958.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644761786","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644761786?lang=zh_cn&edition=full","pubTime":"2026-06-17 01:38","pubTimestamp":1781631490,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，君实生物报收于29.78元，下跌1.39%，换手率1.52%，成交量11.66万手，成交额3.45亿元。当日关注点交易信息汇总：6月16日君实生物主力资金净流出2350.54万元，散户资金净流入3057.55万元。公司公告汇总：持股5%以上股东上海檀英及其一致行动人合计持股比例由7.91%减少至6.94%，权益变动触及1%刻度。大宗交易6月16日君实生物发生1笔大宗交易，成交金额1958.88万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700000623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1515","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643758749","title":"君实生物（688180）披露持股5%以上股东权益变动触及1%刻度公告，6月16日股价下跌1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643758749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643758749?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:40","pubTimestamp":1781602846,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，君实生物报收于29.78元，较前一交易日下跌1.39%，最新总市值为305.75亿元。君实生物于近日披露《关于持股5%以上股东权益变动触及1%刻度的提示性公告》。公告显示，公司持股5%以上股东上海檀英及其一致行动人LVC Fund II、LVC Renaissance Fund因基金期限与流动性资金安排，合计持股比例由7.91%减少至6.94%，权益变动触及1%刻度。本次权益变动不触及要约收购，未导致公司控股股东及实际控制人发生变化，不涉及披露权益变动报告书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600031853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688180","BK0239","BK1583","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643498274","title":"6月15日君实生物发生1笔大宗交易 成交金额1980万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643498274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643498274?lang=zh_cn&edition=full","pubTime":"2026-06-15 17:52","pubTimestamp":1781517163,"startTime":"0","endTime":"0","summary":"证券之星消息，6月15日君实生物发生大宗交易，交易数据如下：大宗交易成交价格30元，相对当日收盘价折价0.66%，成交66万股，成交金额1980万元，买方营业部为中信建投证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生6笔大宗交易，合计成交3.96万手，折价成交6笔。截至2026年6月15日收盘，君实生物报收于30.2元，下跌1.6%，换手率1.76%，成交量13.46万手，成交额4.07亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500023192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1161","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":-0.2094},{"period":"3month","weight":-0.3557},{"period":"6month","weight":-0.2198},{"period":"1year","weight":-0.1976},{"period":"ytd","weight":-0.2198}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0914},{"period":"3month","weight":-0.0954},{"period":"6month","weight":-0.1073},{"period":"1year","weight":-0.0495},{"period":"ytd","weight":-0.1073}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.059343},{"month":4,"riseRate":0.875,"avgChangeRate":0.105939},{"month":5,"riseRate":0.375,"avgChangeRate":-0.021039},{"month":6,"riseRate":0.375,"avgChangeRate":-0.04216},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}